TELA Bio Inc
NASDAQ:TELA
TELA Bio Inc
NASDAQ:TELA
Price:
0.7721
USD
-1.01%
Market Cap:
$33.8m
Balance Sheet
Balance Sheet Decomposition
TELA Bio Inc
TELA Bio Inc
Balance Sheet Decomposition is not available for
TELA Bio Inc
TELA Bio Inc
Balance Sheet
TELA Bio Inc
TELA Bio Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
11
|
17
|
45
|
74
|
44
|
42
|
47
|
53
|
|
| Cash Equivalents |
11
|
17
|
45
|
74
|
44
|
42
|
47
|
53
|
|
| Short-Term Investments |
0
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
3
|
3
|
4
|
7
|
10
|
10
|
|
| Accounts Receivables |
1
|
1
|
3
|
3
|
4
|
7
|
10
|
10
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
2
|
4
|
5
|
4
|
8
|
12
|
13
|
13
|
|
| Other Current Assets |
0
|
0
|
2
|
2
|
3
|
2
|
2
|
3
|
|
| Total Current Assets |
14
|
23
|
64
|
83
|
59
|
62
|
72
|
78
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
1
|
3
|
4
|
4
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
1
|
3
|
4
|
4
|
|
| Accumulated Depreciation |
3
|
3
|
4
|
4
|
4
|
4
|
4
|
5
|
|
| Intangible Assets |
0
|
3
|
3
|
3
|
2
|
3
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Assets |
16
N/A
|
27
+75%
|
68
+149%
|
86
+27%
|
63
-28%
|
68
+9%
|
78
+15%
|
87
+11%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2
|
3
|
3
|
1
|
2
|
2
|
2
|
2
|
|
| Accrued Liabilities |
2
|
5
|
4
|
6
|
8
|
11
|
15
|
13
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
6
|
10
|
7
|
7
|
11
|
12
|
17
|
16
|
|
| Long-Term Debt |
5
|
31
|
30
|
31
|
31
|
40
|
41
|
41
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Total Liabilities |
12
N/A
|
41
+231%
|
37
-10%
|
37
+1%
|
42
+13%
|
54
+26%
|
59
+10%
|
58
-2%
|
|
| Equity | |||||||||
| Common Stock |
111
|
124
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
108
|
138
|
168
|
197
|
230
|
274
|
321
|
359
|
|
| Additional Paid In Capital |
0
|
0
|
199
|
246
|
250
|
288
|
340
|
387
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
14
N/A
|
31
N/A
|
49
+58%
|
20
-59%
|
14
-29%
|
19
+32%
|
28
+51%
|
|
| Total Liabilities & Equity |
16
N/A
|
27
+75%
|
68
+149%
|
86
+27%
|
63
-28%
|
68
+9%
|
78
+15%
|
87
+11%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
11
|
11
|
11
|
14
|
15
|
19
|
24
|
39
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
